Payment overview · 2025
General Payments
$72.59
4 reported records · 1 companies
Healthcare provider profile · identity verified
Jun O Parks, M. D.
Allopathic & Osteopathic Physicians|Internal Medicine · CRANSTON, RI · NPI 1093079006
Verified facts
What the public records show
CMS Open Payments records show Jun O Parks, M. D. received $72.59 in general payments during 2025 across 4 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $72.59 | 100.0% | 4 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $72.59 | 4 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $72.59 | 4 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Furosemide | Furosemide | 791 | 99 |
| Atorvastatin Calcium | Atorvastatin Calcium | 771 | 173 |
| Levothyroxine Sodium | Levothyroxine Sodium | 678 | 70 |
| Eliquis | Apixaban | 597 | 76 |
| Amlodipine Besylate | Amlodipine Besylate | 477 | 120 |
| Lisinopril | Lisinopril | 374 | 80 |
| Trazodone Hcl | Trazodone Hcl | 364 | 96 |
| Sertraline Hcl | Sertraline Hcl | 349 | 66 |
| Omeprazole | Omeprazole | 322 | 80 |
| Gabapentin | Gabapentin | 280 | 69 |
| Losartan Potassium | Losartan Potassium | 279 | 66 |
| Metoprolol Tartrate | Metoprolol Tartrate | 253 | 73 |
| Potassium Chloride | Potassium Chloride | 248 | 44 |
| Metoprolol Succinate | Metoprolol Succinate | 246 | 58 |
| Metformin Hcl | Metformin Hcl | 235 | 55 |
| Quetiapine Fumarate | Quetiapine Fumarate | 232 | 39 |
| Mirtazapine | Mirtazapine | 212 | 52 |
| Escitalopram Oxalate | Escitalopram Oxalate | 196 | 35 |
| Pravastatin Sodium | Pravastatin Sodium | 151 | 39 |
| Pantoprazole Sodium | Pantoprazole Sodium | 150 | 40 |
| Tamsulosin Hcl | Tamsulosin Hcl | 144 | 36 |
| Simvastatin | Simvastatin | 134 | 37 |
| Duloxetine Hcl | Duloxetine Hcl | 125 | 24 |
| Levetiracetam | Levetiracetam | 120 | 20 |
| Januvia | Sitagliptin Phosphate | 111 | 20 |
| Famotidine | Famotidine | 109 | 36 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 106 | 41 |
| Clopidogrel | Clopidogrel Bisulfate | 103 | 23 |
| Metformin Hcl Er | Metformin Hcl | 103 | 24 |
| Prednisone | Prednisone | 101 | 27 |
| Fluticasone Propionate | Fluticasone Propionate | 97 | 34 |
| Alprazolam | Alprazolam | 95 | 13 |
| Jardiance | Empagliflozin | 94 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 92 | 23 |
| Atenolol | Atenolol | 86 | 16 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 81 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 80 | 21 |
| Alendronate Sodium | Alendronate Sodium | 79 | 13 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 77 | 12 |
| Fluoxetine Hcl | Fluoxetine Hcl | 77 | 18 |
| Montelukast Sodium | Montelukast Sodium | 77 | 19 |
| Glipizide | Glipizide | 76 | 16 |
| Myrbetriq | Mirabegron | 72 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 71 | 17 |
| Lorazepam | Lorazepam | 71 | 22 |
| Ropinirole Hcl | Ropinirole Hcl | 71 | 11 |
| Lactulose | Lactulose | 70 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 69 | 41 |
| Carvedilol | Carvedilol | 69 | 16 |
| Cephalexin | Cephalexin | 67 | 27 |
| Allopurinol | Allopurinol | 66 | 17 |
| Hydrochlorothiazide | Hydrochlorothiazide | 62 | 14 |
| Oxycodone Hcl | Oxycodone Hcl | 61 | 12 |
| Spironolactone | Spironolactone | 61 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 60 | 11 |
| Oxybutynin Chloride | Oxybutynin Chloride | 59 | 15 |
| Olanzapine | Olanzapine | 58 | 11 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 57 | 25 |
| Memantine Hcl | Memantine Hcl | 56 | 16 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 56 | 12 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 55 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 55 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 55 | 22 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 53 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 53 | suppressed |
| Sucralfate | Sucralfate | 53 | suppressed |
| Latanoprost | Latanoprost | 51 | 14 |
| Tradjenta | Linagliptin | 51 | suppressed |
| Aripiprazole | Aripiprazole | 50 | suppressed |
| Ondansetron Odt | Ondansetron | 50 | 25 |
| Clonazepam | Clonazepam | 48 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 47 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 46 | suppressed |
| Bupropion Xl | Bupropion Hcl | 45 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 45 | 27 |
| Finasteride | Finasteride | 44 | 13 |
| Meclizine Hcl | Meclizine Hcl | 44 | 15 |
| Lovastatin | Lovastatin | 43 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 42 | suppressed |
| Torsemide | Torsemide | 42 | 12 |
| Azithromycin | Azithromycin | 41 | 22 |
| Propranolol Hcl | Propranolol Hcl | 41 | suppressed |
| Glimepiride | Glimepiride | 40 | suppressed |
| Glipizide Er | Glipizide | 40 | 11 |
| Topiramate | Topiramate | 40 | suppressed |
| Xarelto | Rivaroxaban | 40 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 39 | suppressed |
| Ezetimibe | Ezetimibe | 39 | 12 |
| Doxazosin Mesylate | Doxazosin Mesylate | 38 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 38 | suppressed |
| Verapamil Er | Verapamil Hcl | 38 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 37 | suppressed |
| Bumetanide | Bumetanide | 36 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 36 | 16 |
| Pregabalin | Pregabalin | 35 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 34 | 11 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 34 | 13 |
| Ventolin Hfa | Albuterol Sulfate | 34 | 11 |
| Albuterol Sulfate | Albuterol Sulfate | 33 | suppressed |
| Baclofen | Baclofen | 32 | 11 |
| Gemtesa | Vibegron | 32 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 32 | 15 |
| Trulicity | Dulaglutide | 32 | suppressed |
| Ramelteon | Ramelteon | 31 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 30 | 19 |
| Incruse Ellipta | Umeclidinium Bromide | 30 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 29 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 29 | 18 |
| Erythromycin | Erythromycin Base | 28 | 16 |
| Doxycycline Hyclate | Doxycycline Hyclate | 27 | 15 |
| Morphine Sulfate Er | Morphine Sulfate | 27 | suppressed |
| Acarbose | Acarbose | 26 | suppressed |
| Risperidone | Risperidone | 26 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 25 | suppressed |
| Gemfibrozil | Gemfibrozil | 25 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 24 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 24 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 24 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 23 | suppressed |
| Diazepam | Diazepam | 23 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 23 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 23 | 11 |
| Levofloxacin | Levofloxacin | 23 | 15 |
| Nystatin | Nystatin | 23 | suppressed |
| Valsartan | Valsartan | 23 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 22 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 22 | suppressed |
| Lansoprazole | Lansoprazole | 22 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 22 | suppressed |
| Brilinta | Ticagrelor | 21 | suppressed |
| Primidone | Primidone | 21 | suppressed |
| Amoxicillin | Amoxicillin | 20 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 20 | suppressed |
| Klayesta | Nystatin | 20 | suppressed |
| Permethrin | Permethrin | 20 | 16 |
| Brimonidine Tartrate | Brimonidine Tartrate | 18 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 18 | suppressed |
| Mupirocin | Mupirocin | 18 | 13 |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 18 | 14 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 17 | suppressed |
| Felodipine Er | Felodipine | 17 | suppressed |
| Meloxicam | Meloxicam | 17 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 17 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 17 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 16 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 16 | 12 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 16 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 16 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 16 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 16 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 14 | suppressed |
| Digoxin | Digoxin | 14 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Methocarbamol | Methocarbamol | 14 | suppressed |
| Nifedipine Er | Nifedipine | 14 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 14 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 14 | suppressed |
| Acyclovir | Acyclovir | 13 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 13 | suppressed |
| Linzess | Linaclotide | 13 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 13 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 13 | suppressed |
| Temazepam | Temazepam | 13 | suppressed |
| Timolol Maleate | Timolol Maleate | 13 | suppressed |
| Anastrozole | Anastrozole | 12 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 12 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 12 | suppressed |
| Hydrocortisone | Hydrocortisone | 12 | suppressed |
| Oxycontin | Oxycodone Hcl | 12 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 12 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 12 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 12 | suppressed |
| Entecavir | Entecavir | 11 | suppressed |
| Fenofibrate | Fenofibrate | 11 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 11 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 11 | suppressed |
| Ketoconazole | Ketoconazole | 11 | suppressed |
| Loperamide | Loperamide Hcl | 11 | suppressed |
| Metolazone | Metolazone | 11 | suppressed |
| Naproxen | Naproxen | 11 | suppressed |
| Nitroglycerin | Nitroglycerin | 11 | suppressed |
| Ofloxacin | Ofloxacin | 11 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 11 | 11 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 11 | suppressed |
| Vascepa | Icosapent Ethyl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $72.59 · 4 records | Otsuka America Pharmaceutical, Inc. | REXULTI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error